Pharmaceuticals
Why should you be concerned about Intellectual Property (IP)?
Overview
Pharmaceutical brands operate under complex rules and intense market pressure. Product names, packaging elements and visual identifiers must be safe, clearly distinguishable and compliant with expectations across all EU countries. Even small similarities between names can cause misunderstandings among patients and healthcare professionals.
Why brand protection matters
The EU pharmaceutical market is heavily saturated. Many products use similar naming strategies – short invented terms, prefixes, medical associations, etc. This increases the likelihood of trademark conflicts. Packaging design also plays an essential role in recognition, especially when patients and pharmacists rely on colours, layout and visual codes to avoid errors.
Typical risks
• Name conflicts across different therapeutic areas or OTC products. • EUIPO objections due to weak distinctiveness or similarity with earlier marks. • Competitors adopting similar packaging or visual cues. • Challenges expanding into multiple EU countries because of unclear trademark rights.
How we help
We assess naming risks early, file trademarks for product names and umbrella brands, protect packaging through design registrations and manage communication with EUIPO. We also support companies in opposition proceedings and help coordinate brand strategy across several markets.
Clear and secure brand protection reduces legal uncertainty and supports safe product rollout across the EU.
Related services
Contact us
We will find the best solution for your business
Thank you for your request!
We will contact you within 5 hours!
